JP2016216373A5 - - Google Patents

Download PDF

Info

Publication number
JP2016216373A5
JP2016216373A5 JP2015099432A JP2015099432A JP2016216373A5 JP 2016216373 A5 JP2016216373 A5 JP 2016216373A5 JP 2015099432 A JP2015099432 A JP 2015099432A JP 2015099432 A JP2015099432 A JP 2015099432A JP 2016216373 A5 JP2016216373 A5 JP 2016216373A5
Authority
JP
Japan
Prior art keywords
blood flow
improving agent
agent according
flow improving
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015099432A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016216373A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015099432A priority Critical patent/JP2016216373A/ja
Priority claimed from JP2015099432A external-priority patent/JP2016216373A/ja
Publication of JP2016216373A publication Critical patent/JP2016216373A/ja
Publication of JP2016216373A5 publication Critical patent/JP2016216373A5/ja
Pending legal-status Critical Current

Links

JP2015099432A 2015-05-14 2015-05-14 血流改善剤 Pending JP2016216373A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015099432A JP2016216373A (ja) 2015-05-14 2015-05-14 血流改善剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015099432A JP2016216373A (ja) 2015-05-14 2015-05-14 血流改善剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019079785A Division JP6774065B2 (ja) 2019-04-19 2019-04-19 血流改善剤

Publications (2)

Publication Number Publication Date
JP2016216373A JP2016216373A (ja) 2016-12-22
JP2016216373A5 true JP2016216373A5 (enExample) 2019-03-14

Family

ID=57580370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015099432A Pending JP2016216373A (ja) 2015-05-14 2015-05-14 血流改善剤

Country Status (1)

Country Link
JP (1) JP2016216373A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018124202A1 (ja) * 2016-12-28 2018-07-05 株式会社明治 発汗促進用食品組成物
JP7418170B2 (ja) * 2019-08-30 2024-01-19 小林製薬株式会社 経口組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3183741B2 (ja) * 1993-02-18 2001-07-09 ポーラ化成工業株式会社 顔色改善剤
JP3038202B1 (ja) * 1999-01-18 2000-05-08 日本メナード化粧品株式会社 機能性繊維、その製造方法及び機能性繊維の加工溶液
JP5052011B2 (ja) * 2005-02-10 2012-10-17 株式会社東洋新薬 血流改善剤
JP2009149628A (ja) * 2007-11-29 2009-07-09 Lion Corp 深部体温低下抑制剤
JP2012051833A (ja) * 2010-08-31 2012-03-15 Toyo Shinyaku Co Ltd 血流改善用組成物
JP6400474B2 (ja) * 2012-09-27 2018-10-03 サントリーホールディングス株式会社 肌の状態の改善剤

Similar Documents

Publication Publication Date Title
WO2017218981A3 (en) Compositions and methods for reducing ocular neovascularization
WO2015197530A3 (en) Difluoromethyl-nicotinic-indanyl carboxamides
WO2015159272A3 (en) Curcumin compositions and uses thereof
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
MX2016013575A (es) Composicion para prevenir o tratar enfermedades del higado graso.
BR112018001534A2 (pt) inibidor de isocitrato desidrogenase idh1 r132h mutante
WO2017062468A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
ZA201901370B (en) Formulations for oral administration of active agents
JP2015131825A5 (enExample)
WO2016142708A3 (en) Pharmaceutical composition
WO2016011297A3 (en) Methods and related compositions for improved drug bioavailability and disease treatment
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
EA201791009A1 (ru) Композиции, содержащие циклоспорин
JP2017014155A5 (enExample)
WO2015168488A3 (en) Islet amyloid polypeptides with improved solubility
JP2017012144A5 (enExample)
JP2016216373A5 (enExample)
WO2015001541A3 (en) Pharmaceutical film composition
WO2016178510A3 (ko) 진세노사이드 F1 또는 Rg3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
JP2017008001A5 (enExample)
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2012106058A3 (en) Animal treatments